Introduction. Acute sensorineural hearing loss (ASHL) is one of the common diseases, and the number of patients suffering from this pathology is steadily growing. Therefore, the study and implementation of modern therapeutic measures to eliminate ASHL is considered a relevant issue in otorhinolaryngology. The aim of the study is to analyze the comparative effectiveness of hyperbaric oxygen therapy in the treatment of acute sensorineural hearing loss. Material and methods. The research involved 46 patients with a diagnosis of ASHL I - IV degrees in the period from February, 2018 to November, 2019. All patients were under observation in the ENT department of the multidisciplinary clinic at the TMA. In addition to the prescribed medicinal treatment, the patients underwent HBO treatment consisting of 10-12 sessions course, performed in the pressure chamber "Yenisei" -3 and BLKS-301M. Results and discussions. All clinical examinations were performed in the period before the treatment, after 10 days and 3 months after the treatment. Patients underwent an audiological examination (tonal threshold, speech audiometry), impedancemetry, blood pressure monitoring, as well as a study of the lipid profile and blood rheological parameters. The obtained results were summarized and the average indicators were identified. The following criteria for evaluating the effectiveness of the treatment have been established: decrease in a sound perception threshold; decrease in ear noise; speech intelligibility. Conclusion. The treatment results in the 1st and 2nd groups showed that HBO is most effective in the complex treatment of sensorineural hearing loss. The greatest effectiveness in the treatment of patients with auditory function and reduction of ear noise using the HBO method was observed in patients aged 20 to 41 years with an average hearing loss of 21-40 dB (p <0.05). It can be assumed that HBO, as the treatment method of sensorineural hearing loss, has a greater effect in combination with basic medicine therapy. The best results were obtained in acute forms of the disease, substantiated pathogenetically.
1. Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otology and Neurotology. 2013; 34:1586–89. 2. Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M (2011) Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 268:1735–1741 3. Bennett MH, Kertesz T, Perleth M, Yeung P, Lehm JP (2012) Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 10:CD004739 4. Bennett, M. H., Kertesz, T., Perleth, M., Yeung, P., & Lehm, J. P. (2012). Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database of Systematic Reviews, (10) 5. Bianchin G, Russi G, Romano N et al (2010) Treatment with HELP- apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study. Laryngoscope 120:800–807 6. Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D (2013) Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol 34:1021–1026 7. Cvorovic, L., Jovanovic, M. B., Milutinovic, Z., Arsovic, N., & Djeric, D. (2013). Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otology & Neurotology, 34(6), 1021-1026. 8. Imsuwansri T, Poonsap P, Snidvongs K (2012) Hyperbaric oxygen therapy for sudden sensorineural hearing loss after failure from oral and intratympanic corticosteroid. Clin Exp Otorhinolaryngol 5(Suppl): S99–S102 9. Körpinar S, Alkan Z, Yiğit O, Gör AP, Toklu AS, Cakir B, Soyuyüce OG, Ozkul H (2011) Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 268:41–47 10. Labus J, Breil J, Stutzer H, Michel O (2010) Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope 120:1863–1871 11. Lin RJ, Krall R, Chau JK. Systematic Review and Meta-Analysis of the Risk Factors for Sudden Sensorineural Hearing Loss in Adults. Laryngoscope. 2012;122:624–635 12. Liu S-C, Kang B-H, Lee J-C, Lin YS, Huang KL, Liu DW, Su WF, Kao CH, Chu YH, Chen HC, Wang CH (2011) Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases. Clin Otolaryngol 36:121–128 13. Mosges R, Koberlein J (2009) Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 266:943–953 14. Murphy-Lavoie H, Piper S, Moon RE, Legros T (2012) Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Undersea Hyperb Med: J Undersea Hyperb Med Soc 39(3):777–792 15. Murphy-Lavoie, H., Piper, S., Moon, R. E., & Legros, T. (2012). Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Undersea and Hyperbaric Medicine, 39(3), 777. 16. Muzzi E, Zennaro B, Visentin R, Soldano F, Sacilotto C (2010) Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report. J Laryngol Otol 124:e2 17. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otology & Neurotology. 2012;33:523–531 18. Ohno K, Noguchi Y, Kawashima Y, Yagishita K, Kitamura K (2010) Secondary hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss in the subacute and chronic phases. J Med Dent Sci 57:127–132 19. Quaranta N, Ramunni A, De Luca C, Brescia P, Dambra P, De Tullio G, Vacca A, Quaranta A (2011) Endothelial progenitor cells in sudden sensorineural hearing loss. Acta otolaryngol 131:347–350 e 4 20. Rauch SD, Halpin CF, Antonelli PJ et al (2011) Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 25(305):2071–2079 21. Thom RS (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg 127(Suppl 1):131S–141S
Khasanov, Ulugbek S.; Abdullaev, Ulugbek P.; and Akhmedov, Sulton E.
"COMPLEX TREATMENT OF ACUTE SENSORINEURAL HEARING LOSS USING HYPERBARIC OXYGENATION,"
Central Asian Journal of Medicine: Vol. 2020
, Article 12.
Available at: https://uzjournals.edu.uz/tma/vol2020/iss1/12